BridgeMD
New treatment option for Helicobacter Pylori Infection
Official title Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy
ClinicalTrials.gov ID: NCT07358130
What this study is testing
What is vonoprazan, tripotassium dicitrate bismuthate, amoxicilline?
vonoprazan, tripotassium dicitrate bismuthate, amoxicilline is an investigational medicine, being studied as a potential treatment for helicobacter pylori infection.
Also referred to as triple therapy.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- (1) To compare the efficacy and safety of a 14-day bismuth-amoxicillin-vonoprazan triple therapy versus a 14-day bismuth-based quadruple therapy as first-line treatments for H. pylori infection, and (2) To investigate the influence of H.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- people with Helicobacter pylori infection
You likely can't join if
- people with known hypersensitivity to the study drug.
- people with a history of gastric surgery.
- people with severe liver cirrhosis or uremia.
- people with a history of malignancy within the past five years.
- Pregnant or breastfeeding women.
- people currently receiving treatment with atazanavir sulfate or rilpivirine hydrochloride.
The study team makes the final eligibility decision.
Where it's taking place
- Kaohsiung City, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kaohsiung City, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.